Lakshmi Sriharsha

Statistics

Publications

Citations

227

H-Index

Active since

2008

Affiliations

Samsung Medical Center(Current)

University of Toronto

University Health Network

Sungkyunkwan University

Princess Margaret Cancer Centre

Lakshmi Sriharsha is an author at Samsung Medical Center specializing in chronic myeloid leukemia therapy, cytogenetic prognostic markers, and genetics.

Publications per year

2008–2010

Publications

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia

Dong‐Hwan Kim, Lakshmi Sriharsha, Wei Xu et al. · Clinical Cancer Research · 2009 · 186 citations

Veterinary Medicine, Genetics, Pharmacology +15

No significance of derivative chromosome 9 deletion on the clearance kinetics of <i>BCR</i>/<i>ABL</i> fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia

Dong‐Hwan Kim, Gizelle Popradi, Lakshmi Sriharsha et al. · Cancer · 2008 · 31 citations

Life Sciences, Genetics, Hematology +16

Comprehensive evaluation of time‐to‐response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time‐point does matter?

Dong‐Hwan Kim, Lakshmi Sriharsha, Chul Won Jung et al. · American Journal of Hematology · 2010 · 10 citations · Full text

Public Health, Biostatistics, Oncology +17

1–3 of 3